Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference
TORONTO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that management will participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference, including a fireside chat and one-on-one investor meetings.